white-paper

name	white-paper
description	Generate authoritative white papers on clinical trial technology topics with research-backed content, references, data visualization concepts, and gate-worthy lead generation value.

White Paper Generation for Talosix EDC

Purpose

Produce in-depth white papers that establish Talosix as a thought leader in clinical trial technology. White papers serve as premium gated content for lead generation, targeting mid-funnel prospects who are researching solutions and evaluating approaches to clinical data management challenges.

White Paper Types

1. Industry Trends and Analysis

• Examines a macro trend affecting clinical trial data capture
• Example: "The State of Clinical Trial Data Capture: 2026 Trends and Predictions"
• Positions Talosix as a knowledgeable industry participant
• Heavy on third-party data and industry references

2. Best Practice Guide

• Provides actionable guidance on a specific clinical operations topic
• Example: "The Definitive Guide to eCRF Design for Complex Protocols"
• Positions Talosix as a subject matter expert
• Practical frameworks and checklists the reader can apply

3. Technology Deep Dive

• Explores a technical capability or architectural approach
• Example: "API-First EDC: Why Integration Architecture Matters for Clinical Data"
• Targets technical evaluators (IT, validation, data management leads)
• Includes architecture diagrams and technical specifications

4. Problem-Solution Paper

• Identifies a specific industry problem, analyzes causes, presents solution approach
• Example: "Solving the Query Rate Problem: How Intelligent Edit Checks Transform Data Quality"
• Directly supports sales conversations and objection handling
• Includes case data and before/after metrics

5. Regulatory Guidance Paper

• Interprets regulatory requirements and their practical implications
• Example: "21 CFR Part 11 Compliance for Modern Cloud EDC: A Practical Guide"
• Targets compliance and quality teams
• Must be carefully reviewed for regulatory accuracy

White Paper Structure

Standard Length: 2,500-5,000 words (8-15 pages when designed)

1. Cover Page

• Title (compelling, specific, keyword-rich)
• Subtitle (clarifying scope or audience)
• Talosix branding
• Publication date

2. Executive Summary (200-300 words)

• The problem or opportunity in 2-3 sentences
• What this paper covers
• Key findings or recommendations (3-4 bullet points)
• Who should read this and what they will gain

3. Introduction / Problem Statement (300-500 words)

• Context: Why this topic matters now
• Scope of the problem with data points
• Impact on clinical trial stakeholders
• What is at stake if the problem is not addressed

4. Background / Current State (400-600 words)

• How the industry currently handles this challenge
• Limitations of current approaches
• Relevant regulatory framework
• Market data and industry benchmarks

5. Analysis / Core Content (800-1,500 words)

• The substance of the paper — this is where thought leadership lives
• Present a framework, methodology, or analysis
• Support every major claim with data, references, or expert insight
• Use subheadings to break into digestible sections
• Include 2-3 data visualization concepts (charts, diagrams, comparison tables)

6. Solution Approach (500-800 words)

• How to address the challenge (methodology, not product pitch)
• Best practices and recommendations
• Where Talosix capabilities align (subtle, educational framing)
• Implementation considerations

7. Case Evidence (300-500 words)

• Real-world example or anonymized customer data
• Before/after metrics
• Lessons learned
• Reinforces the paper's thesis with proof

8. Recommendations / Key Takeaways (200-300 words)

• 5-7 actionable recommendations numbered or bulleted
• Prioritized by impact and feasibility
• Practical enough to apply regardless of EDC vendor

9. Conclusion (150-200 words)

• Restate the core thesis
• Forward-looking statement
• Invitation to continue the conversation (soft CTA)

10. About Talosix (100-150 words)

• Company description focused on mission and approach
• Relevant credentials and differentiators
• Website and contact information
• CTA: "Learn more at talosix.com" or "Request a demonstration"

11. References

• Numbered footnotes or endnotes
• Minimum 8-12 references for credibility
• Include regulatory documents, peer-reviewed publications, industry reports

Research and References

Acceptable Source Types

• Regulatory documents: ICH guidelines (E6, E8, E9), FDA guidance documents, EMA guidelines, 21 CFR Part 11
• Industry reports: Tufts CSDD, IQVIA, McKinsey, Deloitte life sciences reports
• Standards bodies: CDISC publications, HL7, TransCelerate
• Peer-reviewed journals: Clinical Trials (journal), Therapeutic Innovation & Regulatory Science, Drug Information Journal
• Conference proceedings: DIA, SCOPE, ACRP
• Trade publications: Applied Clinical Trials, Clinical Leader, Outsourcing Pharma
• Government data: ClinicalTrials.gov statistics, FDA inspection databases

Reference Standards

• Cite specific sections/pages, not just document titles
• Include publication date for all references
• Use consistent citation format (author, title, source, date, URL if online)
• Distinguish between direct quotes, paraphrased findings, and general references
• Do not fabricate statistics. If a specific number is not available, use qualitative language or cite the general finding with its source.

Data Visualization Concepts

White papers should include 3-5 visual elements. Provide detailed descriptions for the design team.

Types to Use

• Comparison tables: Feature comparison, before/after, vendor evaluation criteria
• Process flow diagrams: Clinical data flow, study build workflow, query lifecycle
• Bar/column charts: Survey results, metric comparisons, time savings
• Line charts: Trend data over time (query rates, adoption curves)
• Infographics: Key statistics callouts, process steps, decision trees
• Architecture diagrams: System integration, data flow, technology stack (for technical papers)

Visualization Brief Format

Visual [number]: [Descriptive title]
Type: [Chart/table/diagram type]
Data: [Specific data points to include or source to reference]
Purpose: [What insight the reader should take away]
Placement: [Which section it supports]

Tone and Style

• Authoritative: Write as a knowledgeable industry participant, not a vendor making claims
• Evidence-based: Every major assertion backed by data or reference
• Balanced: Acknowledge complexity and trade-offs; avoid oversimplification
• Educational: Reader should learn something valuable even if they never buy Talosix
• Professional: Formal but not academic. Avoid passive voice where active is clearer.
• Vendor-neutral framing: Present the problem and approach objectively. Talosix mention limited to solution section and about section.

Writing Calibration

• Assume the reader is a clinical trial professional with 5-10 years experience
• Define acronyms on first use: "Electronic Data Capture (EDC)"
• Avoid consumer marketing language in the body (save CTAs for appropriate sections)
• Use data-specific language: "reduced by 47%" not "significantly reduced"

Gating and Lead Generation Strategy

Gate Decision Framework

• Gate (require form): Papers with original research, frameworks, or comprehensive guides
• Ungate: Regulatory summaries, brief opinion pieces, content older than 12 months
• Partial gate: Show executive summary and first section; gate the full paper

Form Fields for Gated White Papers

• Required: Name, business email, company name, job title
• Optional: Phone number, number of active studies, current EDC system
• Include: Consent checkbox, privacy policy link

Landing Page for Each White Paper

• Compelling title and subtitle
• 3-4 bullet points on what the reader will learn
• Author credentials (if named author)
• Thumbnail of cover page
• Download form
• Trust signals (company logos, "Downloaded by X+ professionals")

Production Workflow

1. Topic selection: Align with content calendar, sales needs, keyword strategy
2. Research phase: Gather sources, data, and expert input (1-2 weeks)
3. Outline review: Marketing and subject matter expert approve outline
4. First draft: Write complete draft (1 week)
5. SME review: Product, clinical, or technical expert reviews for accuracy
6. Marketing review: Tone, brand, CTA alignment
7. Legal review: If regulatory claims or customer data included
8. Design: Professional layout with brand template (1 week)
9. Final proofread: Fresh eyes, check all references and links
10. Publish: Upload, create landing page, set up lead routing

Output Deliverables

When generating a white paper, provide:

1. Detailed outline with section descriptions and word count targets
2. Full draft text for all sections
3. Data visualization briefs for 3-5 visuals
4. Reference list with complete citations
5. Executive summary (standalone, usable for promotion)
6. Landing page copy for the gated download
7. 2 promotional email variants
8. 3 social media posts for promotion